DPOGS203565 | ||
---|---|---|
Transcript | DPOGS203565-TA | 1512 bp |
Protein | DPOGS203565-PA | 503 aa |
Genomic position | DPSCF300055 + 625809-629161 | |
RNAseq coverage | 2233x (Rank: top 5%) |
Annotation | ||||
---|---|---|---|---|
Heliconius | HMEL002834 | 0.0 | 87.14% |   |
Bombyx | BGIBMGA008304-TA | 0.0 | 78.93% |   |
Drosophila | Akt1-PC | 0.0 | 66.06% |   |
EBI UniRef50 | UniRef50_Q8INB9 | 0.0 | 66.06% | RAC serine/threonine-protein kinase n=24 Tax=Bilateria RepID=AKT1_DROME |
NCBI RefSeq | XP_968049.2 | 0.0 | 69.82% | PREDICTED: similar to rac serine/threonine kinase [Tribolium castaneum] |
NCBI nr blastp | gi|343796623 | 0.0 | 87.28% | serine/threonine protein kinase Akt [Helicoverpa armigera] |
NCBI nr blastx | gi|343796623 | 0.0 | 87.45% | serine/threonine protein kinase Akt [Helicoverpa armigera] |
Group | ||||
---|---|---|---|---|
Gene Ontology | GO:0005524 | 1.7e-103 | ATP binding | |
GO:0004674 | 1.7e-103 | protein serine/threonine kinase activity | ||
GO:0006468 | 1.7e-103 | protein phosphorylation | ||
GO:0016772 | 6.2e-94 | transferase activity, transferring phosphorus-containing groups | ||
GO:0004672 | 6.2e-72 | protein kinase activity | ||
GO:0005515 | 6e-22 | protein binding | ||
GO:0004713 | 1.8e-11 | protein tyrosine kinase activity | ||
KEGG pathway | tca:656423 | 0.0 |   | |
  | K04456 (AKT) | maps-> | Prostate cancer | |
  |   |   | Fc epsilon RI signaling pathway | |
  |   |   | Toll-like receptor signaling pathway | |
  |   |   | MAPK signaling pathway | |
  |   |   | Fc gamma R-mediated phagocytosis | |
  |   |   | Glioma | |
  |   |   | B cell receptor signaling pathway | |
  |   |   | Melanoma | |
  |   |   | Pathways in cancer | |
  |   |   | Chemokine signaling pathway | |
  |   |   | Adipocytokine signaling pathway | |
  |   |   | Endometrial cancer | |
  |   |   | Chagas disease | |
  |   |   | Insulin signaling pathway | |
  |   |   | Neurotrophin signaling pathway | |
  |   |   | T cell receptor signaling pathway | |
  |   |   | Focal adhesion | |
  |   |   | ErbB signaling pathway | |
  |   |   | Colorectal cancer | |
  |   |   | mTOR signaling pathway | |
  |   |   | Tight junction | |
  |   |   | Progesterone-mediated oocyte maturation | |
  |   |   | Apoptosis | |
  |   |   | Renal cell carcinoma | |
  |   |   | Small cell lung cancer | |
  |   |   | Pancreatic cancer | |
  |   |   | Acute myeloid leukemia | |
  |   |   | Non-small cell lung cancer | |
  |   |   | Jak-STAT signaling pathway | |
  |   |   | Chronic myeloid leukemia | |
  |   |   | VEGF signaling pathway | |
InterPro domain | [158-415] IPR002290 | 1.7e-103 | Serine/threonine-protein kinase domain | |
[153-499] IPR011009 | 6.2e-94 | Protein kinase-like domain | ||
[158-415] IPR017442 | 6.2e-72 | Serine/threonine-protein kinase-like domain | ||
[7-114] IPR011993 | 6e-22 | Pleckstrin homology-type | ||
[416-480] IPR000961 | 1.1e-16 | AGC-kinase, C-terminal | ||
[9-112] IPR001849 | 3.6e-16 | Pleckstrin homology domain | ||
[158-410] IPR020635 | 1.8e-11 | Tyrosine-protein kinase, catalytic domain | ||
[435-478] IPR017892 | 2.6e-10 | Protein kinase, C-terminal | ||
Orthology group | MCL11287 |   | Multiple-copy universal gene |
Genotypes for resequenced monarchs and outgroup Danaus species |
---|
>DPOGS203565-TA
ATGGCGGAGGCGGCGCCCGGGAATATCGTGAAGGAGGGCTGGTTGCTGAAGCGCGGCGAGCACATCCGTAACTGGCGCGACCGCTACTTCATCCTGTTCGACAATGGCGACCTACTGGGATTCAAGGCGCAGCCCGAGCGCAACAACTACCGTGACACCCTCAACAAGTTTACAGTGCGCGATTGTCAGATCATGGCTGTAGACAAACCCCGGCCCTACGTGTTCACGATTCGTGGCCTACAGTGGACTACCGTCATAGAAAGAAACTTCGCCGTCGACAACGAGAAGGATCGCGAGGAGTGGGTGGCGGCTATCCGCTATGTATCGTCGACCCTGGCGGCGGGCTCGGCGGCCGGGGAGGGTGCGTCGGGGGCTCTCGGCGGTGTTCTCCCTCCGCACGACACCGACGACGATGACATCGCCAAGCTCGGCACCAGCTTCAGGGATCCGAGACGCATCACCTTGGAGAAGTTTGAGTTCGTGAAGGTCCTGGGGAAGGGGACCTTCGGGAAGGTGGTGCTCAGTAGAGAAAAGGGAACCGGCAAGCTTTACGCCATGAAGATACTGAAGAAACACATCATCATACAGAAGGACGAGGTCGCGCACACCATCACCGAGAACCACGTGCTCAAGAAGACCAAACATCCATTCCTTACGGCGCTGCGTTACTCGTTCCAAACGGCAGACCGCGTGTGTTTCGTGATGGAGTACGCCAACGGCGGGGAACTGTTCTTTCATCTTTCGCGAGTGAGATCCTTCAGCGAGGAGCGGACGCGCTTCTACGGCGCCGAGATCGTGGCGGCGCTGGGGTACCTGCATGCCGAGGGCATCATATACAGGGATCTTAAGCTTGAGAATCTTCTCCTGGACAAGGACGGCCACATCAAGATCGCCGACTTCGGACTGTGCAAGGTCGACATCACGTACGGCCGGACGACCAAGACGTTCTGCGGCACTCCGGAGTACCTCGCGCCCGAGGTGCTGGAGGACACGGATTACGGGCCGGCCGTGGACTGGTGGGGCACCGGCGTGGTGCTGTACGAGATGGTGTGCGGTCGCCTGCCCTTCTACAACAGGGACCACGAGGTGCTGTTCGAGCTCATCTTGCAGGAGGAGGTGCGCTTCCCCCGCGCGTTGTCGGCCGCCTGCCGCTCGCTGCTGGCCGGCCTGCTGTGCAAGGAGCCCGCCGGCCGCCTGGGCGCCGGCCCCGACGACGCCAAGGAGATCATGCAGCATCCCTTCTTCACGTCCGTCAACTGGAGCGACCTCGTCGCCAAGAAGATTCCGCCGCCCTTCAAGCCGCAGGTGGACTCGGACACCGACACGCGCTACTTCGACTCGGAGTTCACGGGCGAATCCGTGGAACTCACGCCGCCCGATAACGACTCCGGCCTCGCGCGCATCCAGGAGGAGCACTTCCCGCAGTTCTCGTACCAGGACATCTGCTCGTCGGCGCACTCGGCCCTGTCTCACCTGTCGCACCACTCCGCCGCGCCCGACCGCCGCCACTAG
>DPOGS203565-PA
MAEAAPGNIVKEGWLLKRGEHIRNWRDRYFILFDNGDLLGFKAQPERNNYRDTLNKFTVRDCQIMAVDKPRPYVFTIRGLQWTTVIERNFAVDNEKDREEWVAAIRYVSSTLAAGSAAGEGASGALGGVLPPHDTDDDDIAKLGTSFRDPRRITLEKFEFVKVLGKGTFGKVVLSREKGTGKLYAMKILKKHIIIQKDEVAHTITENHVLKKTKHPFLTALRYSFQTADRVCFVMEYANGGELFFHLSRVRSFSEERTRFYGAEIVAALGYLHAEGIIYRDLKLENLLLDKDGHIKIADFGLCKVDITYGRTTKTFCGTPEYLAPEVLEDTDYGPAVDWWGTGVVLYEMVCGRLPFYNRDHEVLFELILQEEVRFPRALSAACRSLLAGLLCKEPAGRLGAGPDDAKEIMQHPFFTSVNWSDLVAKKIPPPFKPQVDSDTDTRYFDSEFTGESVELTPPDNDSGLARIQEEHFPQFSYQDICSSAHSALSHLSHHSAAPDRRH-